Nevertheless, since the association of several breast cancer risk factors with estimated fragmented IGFBP-3 was quite different from their association with intact IGFBP-3, our results suggest that further studies should measure levels of fragmented IGFBP-3 using specific assays and should examine intact and fragmented IGFBP-3 separately. The gene discussed is IGFBP3; the disease is breast cancer.